Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. #TIJC 3

Date

16 janv. 2025

Time

4:00 PM – 5:00 PM

Place

online webinar

WEBINAR Transdisciplinary Immunology Journal Club
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed.
With Dr Marie ROBERT
Thursday, January 16, 2025 from 4:00 PM to 5:00 PM
Revoir en Replay TIJC#3 ICI :

Revoir en Replay TIJC#1
JAK Inhibitors and Cancer: Friend or Foe? Par le Dr Samuel Bitoun, disponible ICI

Revoir en Replay TIJC#2
The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024. Par le Dr François-Xavier Danlos, disponible ICI